SMTL ID : 7aw1.1

MerTK kinase domain in complex with a type 2 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.98 Å

Oligo State

monomer

Ligands

1 x S4T: N-(6-(4-(3-(4-((5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)methyl)-3-(trifluoromethyl)phenyl)ureido)phenoxy)pyrimidin-4-yl)cyclopropanecarboxamide(Non-covalent)

S4T.1: 20 residues within 4Å: Chain A: V.35, A.51, K.53, E.71, M.75, F.78, I.84, L.105, P.106, F.107, M.108, K.109, G.111, F.153, H.155, M.164, V.173, A.174, D.175, F.176 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:K.53, A:L.105, A:F.107, A:D.175, A:F.176 Hydrogen bonds: A:M.108, A:M.108, A:D.175 Halogen bonds: A:V.173

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nissink, J.W.M. et al., Generating Selective Leads for Mer Kinase Inhibitors-Example of a Comprehensive Lead-Generation Strategy. J.Med.Chem. (2021)

Release Date

2021-03-03

Peptides

Tyrosine-protein kinase Mer: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase Mer

Related Entries With Identical Sequence